{
    "organizations": [],
    "uuid": "4cb1d14a0c5ba1b2f00a92090efba7a61807d126",
    "author": "",
    "url": "https://www.reuters.com/article/brief-jazz-pharmaceuticals-enrolls-first/brief-jazz-pharmaceuticals-enrolls-first-patient-in-clinical-trial-of-defibrotide-idUSASB0C79X",
    "ord_in_thread": 0,
    "title": "BRIEF-Jazz Pharmaceuticals Enrolls First Patient In Clinical Trial of Defibrotide",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 23, 2018 / 2:10 PM / Updated 10 minutes ago BRIEF-Jazz Pharmaceuticals Enrolls First Patient In Clinical Trial of Defibrotide Reuters Staff 1 Min Read Feb 23 (Reuters) - Jazz Pharmaceuticals Plc: * JAZZ PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 2 CLINICAL TRIAL EVALUATING DEFIBROTIDE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE Source text for Eikon: Further company coverage:",
    "published": "2018-02-23T16:09:00.000+02:00",
    "crawled": "2018-02-23T16:23:09.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "enrolls",
        "first",
        "patient",
        "clinical",
        "trial",
        "defibrotide",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "jazz",
        "pharmaceutical",
        "plc",
        "jazz",
        "pharmaceutical",
        "announces",
        "first",
        "patient",
        "enrolled",
        "phase",
        "clinical",
        "trial",
        "evaluating",
        "defibrotide",
        "prevention",
        "acute",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}